Wal-Mart stirred up a maelstrom of controversy when it launched its $4 generic drug prescription program in September. This initiative, which is now national, caused many supermarkets and other mass merchants like Target, to respond with offers that matched and, in some cases, exceeded, Wal-Mart. The major drug chains have so far elected to stay on the sidelines. Answering whether such pricing is good, bad or indifferent is beyond the scope of this column. What can be said is that these ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.